PaxVax
Gaithersburg · Founded 2007
About PaxVax
PaxVax is a vaccine start-up company developing candidate oral vaccines for influenza, and key infectious diseases. It has developed a proprietary oral vaccine technology based on a common virus called adenovirus. The technology removes the delivery hurdles of traditional injectable vaccines, namely the need for cold storage, needles, and administration by medical personnel. PaxVax was founded in 2007 and is headquartered in Gaithersburg, Maryland.
Company Facts
- Founded: 2007
- Legal name: PaxVax, Inc.
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Total funding: $234.6M
- Funding stage: M&A
- Last round: Private Equity (Dec 2015)
- Website: paxvax.com
- Phone: 8584500544
Social Profiles
Canonical: https://fsome.com/organization/paxvax-8356898 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.